Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
APICAL: Adjuvant Pemetrexed + Cisplatin in Lung Adenocarcinoma
NCT02498860Phase 2Completed
- Sponsor
- Chonnam National University Hospital
- Start
- Sep 2015
- Primary completion
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pemetrexed in lung adenocarcinoma, sponsored by Chonnam National University Hospital. Started Sep 2015; status: completed.
02
Drugs
pemetrexed
03
Conditions
lung adenocarcinoma
Beyond the preview
Go deeper on NCT02498860.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02498860.